Clinical Study of Acute Monocytic Leukaemia

ZHANG Jing,QIN Tiejun,MI Yingchang,WANG Ying,LIU Kaiqi,WANG Huijun,LIU Xuping,PIAN Shougeng,WANG Jianxiang
DOI: https://doi.org/10.3969/j.issn.1004-2806.2010.05.008
2010-01-01
Abstract:Objective:To analyze the clinical and biological characteristics and prognosis of acute monocytic leukaemia.Method:183 patients were enrolled.Clinical feature,immunophenotype,chromosome karyotype,therapy and survival were analyzed.Result:①158 patients received induction therapy.The complete remission(CR) rate was 74.1%.And CR rate was higher in the patients who received mHAD than the others.②Normal and abnormal chromosome karyotypes accounted for 55.9% and 40.4%,respectively.The CR rate,OS and DFS rates in intermediate prognostic group were higher than in poor prognostic group,but there was no difference between intermediate prognostic group and unknown group.③The OS and DFS rates of the CR patients who received intermediate dose Ara-C were higher than those who received standard dose Ara-C for induction and consolidation therapy.Patient who received two or more courses of consolidation therapy may have a better survival.④Chromosome karyotype,CD11b(+) and the course of consolidation therapy had more important influence on survival by COX analysis.Conclusion:Poor prognostic karyotypes were common in M5,intensive chemotherapy(including induction chemotherapy and post-remission chemotherapy) can improve prognosis of AML-M5.Chromosome karyotype,CD11b(+) and the course of consolidation therapy had important influence on survival.
What problem does this paper attempt to address?